The Princeton-based startup said the move was related to “a revenue mix shift within the Noom business" driven by a change in ...

Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year, and brushed off fears of the company falling behind Eli Lilly & Co. Details about its next-generation weight loss drugs ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Noom Med includes access to a licensed healthcare professional who will work with you to create a personalized plan, which may include a prescription for a weight loss medication. Available ...

The weight loss App Market thrives on rising health awareness, AI integration, and demand for personalized, holistic weight management solutions.

Keeping track of your health is, for many people, a continuous task. Monitoring what you eat, how often you exercise and how much water you drink can be time-consuming. Seeing a market there, apps ...

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today unveiled two ...

Zepbound is the newest GLP-1 medication to be approved by the Food and Drug Administration (FDA) for weight loss. It’s available only by prescription for people with a body mass index (BMI) of ...

Dana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the ...

“Nearly 100% of weight loss attempts fail after five years, and people may abandon exercise programs simply because they do not see the number on the scale change.” The study has some ...